Flavonoids Against Cancer Hallmarks
- 1st Edition - June 1, 2026
- Latest edition
- Authors: Dharambir Kashyap, Riya Sharma
- Language: English
Flavonoids Against Cancer Hallmarks provides an in-depth exploration of the anti-cancer potential of flavonoids, plant-derived bioactive compounds, by targeting key cancer hallma… Read more
Flavonoids Against Cancer Hallmarks provides an in-depth exploration of the anti-cancer potential of flavonoids, plant-derived bioactive compounds, by targeting key cancer hallmarks. It encompasses a thorough analysis of flavonoids' sources, bioavailability, metabolic disposition, long-term safety, and adverse effects. The book highlights the mechanisms through which flavonoids inhibit cancer growth and proliferation, focusing on their immunomodulatory, anti-angiogenic, anti-metastatic, and cell cycle inhibitory effects. Designed for oncology specialists, pharmacology and pharmacy students, cancer research scholars, and pharmaceutical industry researchers, this comprehensive guide also reviews recent cancer epidemiology and updates on existing therapeutic strategies. By detailing how flavonoids counteract cancer stemness and influence immune responses, this book offers innovative insights into utilizing plant-derived compounds for cancer treatment. Flavonoids Against Cancer Hallmarks stands out by providing a detailed overview of flavonoids' cellular and molecular mechanisms and evaluating the pros and cons of current therapeutic options, making it essential reading for a global audience.
- Explores the anti-cancer mechanisms of flavonoids in detail
- Reviews recent advancements in cancer epidemiology and therapeutic strategies
- Highlights the immunomodulatory, anti-angiogenic, and anti-metastatic effects of flavonoids
Oncology physicians and specialists in pharmacology and pharmacy
1. Recent Update on Cancer Epidemiology
2. Pros and Cons of Currently Available Chemotherapy
3. Flavonoids, Their Classification, Chemistry, and Therapeutic Potential Against Different Types of Cancer
4. Source of Flavonoid, Mode of Intake, Bioavailability and Possible Toxicity
5. Flavonoids Against Immune Evasion During Carcinogenesis
6. Apoptosis Inducing Potential of Flavonoids in Cancer
7. Flavonoids As Cell Cycle Inhibitors in Cancer
8. Flavonoids with Anti-angiogenetic Potential in Cancer
9. Flavonoids As Promising Plant Derived Agents Against Cancer Invasion and Metastasis
10. Promising Function of Flavonoid in the Inhibit of Epithelial to Mesenchymal Transition
11. Flavonoids Mediated Regulation of Cancer Stemness Phenotype
12. Role of Flavonoids in Epigenetic Regulation: A Mechanism for Their Anti-cancer Potential
13. Synergistic Effects of Flavonoids with Other Anti-cancer Drugs: With Special References to Targeted and Immunotherapy
14. Clinical Implication of Flavonoid: Integration with Clinical Trials and Future Directions
2. Pros and Cons of Currently Available Chemotherapy
3. Flavonoids, Their Classification, Chemistry, and Therapeutic Potential Against Different Types of Cancer
4. Source of Flavonoid, Mode of Intake, Bioavailability and Possible Toxicity
5. Flavonoids Against Immune Evasion During Carcinogenesis
6. Apoptosis Inducing Potential of Flavonoids in Cancer
7. Flavonoids As Cell Cycle Inhibitors in Cancer
8. Flavonoids with Anti-angiogenetic Potential in Cancer
9. Flavonoids As Promising Plant Derived Agents Against Cancer Invasion and Metastasis
10. Promising Function of Flavonoid in the Inhibit of Epithelial to Mesenchymal Transition
11. Flavonoids Mediated Regulation of Cancer Stemness Phenotype
12. Role of Flavonoids in Epigenetic Regulation: A Mechanism for Their Anti-cancer Potential
13. Synergistic Effects of Flavonoids with Other Anti-cancer Drugs: With Special References to Targeted and Immunotherapy
14. Clinical Implication of Flavonoid: Integration with Clinical Trials and Future Directions
- Edition: 1
- Latest edition
- Published: June 1, 2026
- Language: English
DK
Dharambir Kashyap
Dr. Kashyap is currently at the Brown Center for Immunotherapy, Indiana University, working on identifying novel biomarkers for designing and modifying immunotherapy approaches for breast cancer targeting TME components. He received his PhD in molecular biology on the main subject of tumor microenvironment in breast cancer from PGIMER, Chandigarh, India, and holds an MSc in Human Genomics. He published 70 articles and five book chapters. He is also a reviewer and editorial board member of many PubMed/Scopus-indexed journals. His h-index is 26, and FWCI is 2.91
Affiliations and expertise
Brown Center for Immunotherapy, Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USARS
Riya Sharma
Dr. Sharma is an early career scientist in biological science at the School of Medicine, Indiana University Indianapolis, USA, working on Multiple Myeloma genomics characterizations. She holds an MSc in Microbial Biotechnology and has good publications in peer-reviewed international journals.
Affiliations and expertise
Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA